Michael W. Dunne - Oct 1, 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Michael W. Dunne
Stock symbol
ITRM
Transactions as of
Oct 1, 2023
Transactions value $
$0
Form type
4
Date filed
10/2/2023, 09:20 AM
Previous filing
Jul 3, 2023
Next filing
Nov 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise +3.49K +6.31% 58.8K Oct 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -3.49K -100% $0.00* 0 Oct 1, 2023 Ordinary Shares 3.49K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 On December 23, 2022, the reporting person was granted an award of 3,487 RSUs, which vested in full on October 1, 2023.